SARS-CoV-2 mRNA Vaccine Elicits Sustained T Cell Responses Against the Omicron Variant in Adolescents

Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been acknowledged as an effective mean of preventing infection and hospitalization. However, the emergence of highly transmissible SARS-CoV-2 variants of concern (VOCs) has led to substantial increase in infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Sujin, Kim, Sang-Hoon, Han, Mi Seon, Yoon, Yoonsun, Kim, Yun-Kyung, Cho, Hye-Kyung, Yun, Ki Wook, Song, Seung Ha, Ahn, Bin, Kim, Ye Kyung, Choi, Sung Hwan, Choe, Young June, Lim, Heeji, Choi, Eun Bee, Kim, Kwangwook, Hyeon, Seokhwan, Lim, Hye Jung, Kim, Byung-chul, Lee, Yoo-kyoung, Choi, Eun Hwa, Shin, Eui-Cheol, Lee, Hyunju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Immunologists 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475828/
https://www.ncbi.nlm.nih.gov/pubmed/37670807
http://dx.doi.org/10.4110/in.2023.23.e33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475828/
https://www.ncbi.nlm.nih.gov/pubmed/37670807
http://dx.doi.org/10.4110/in.2023.23.e33

Ejemplares similares